RegeneRx Issued Major U.S. Heart Patent
RegeneRx Issued Major U.S. Heart Patent
RegeneRx Biopharmaceuticals, Inc. today announced that it has been issued a patent from the U.S. Patent and Trademark Office claiming methods for treating, preventing, inhibiting or reducing tissue deterioration due to congestive heart failure disease using Thymosin beta 4 , its isoforms and fragments, and important analogs.